Serum Galectin-3 Level as a Marker of Thrombogenicity in Atrial Fibrillation

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Galectin 3 and Incident Atrial Fibrillation in the Community

American Heart Journal
Cardiovascular MedicineCardiology
2014English

Galectin-3 in Patients With Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

The Significance of Galectin-3 as a New Basal Cell Marker in Prostate Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Atrial Enlargement as a Consequence of Atrial Fibrillation.

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Serum Level of SHAP as a Disease Marker: A Comparison With Hyaluronan

Trends in Glycoscience and Glycotechnology
BiochemistryOrganic Chemistry
2010English

Atrial Ectopy as a Predictor of Incident Atrial Fibrillation

Annals of Internal Medicine
Internal MedicineMedicine
2013English

Serum Galectin-3 Levels Are Decreased in Schizophrenia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy